F.D.A. Approves GHB, a'Date Rape' Drug, for Narcolepsy Patients
Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval, sales could soar. (Source: NYT Health)
Source: NYT Health - August 12, 2021 Category: Consumer Health News Authors: Virginia Hughes Tags: Drugs (Pharmaceuticals) Sedatives Narcolepsy Sleep Food and Drug Administration Jazz Pharmaceuticals Inc Drug Abuse and Traffic Source Type: news
What to Know When Your Child Has Narcolepsy
Narcolepsy is a disorder that affects the brain’s ability to control sleep and alertness. Without proper treatment, it can hinder your child’s school, social, and personal life. Learn more about how to support your child though their condition. (Source: WebMD Health)
Source: WebMD Health - July 26, 2021 Category: Consumer Health News Source Type: news
Complementary and Alternative Treatments for Narcolepsy
If you have narcolepsy, certain complementary or alternative medicines like yoga or herbal teas may help ease or manage some of the symptoms. (Source: WebMD Health)
Source: WebMD Health - July 23, 2021 Category: Consumer Health News Source Type: news
Tips and Tricks to Manage Narcolepsy Day-to-Day
Narcolepsy can make life complicated, but with the help of a sleep doctor and some tips and tricks to get you through the day, you can manage your days better. (Source: WebMD Health)
Source: WebMD Health - July 20, 2021 Category: Consumer Health News Source Type: news
Is Narcolepsy an Autoimmune Disorder?
We look at evidence that points to narcolepsy as an autoimmune disorder and what that could mean for diagnosis and treatment. (Source: WebMD Health)
Source: WebMD Health - July 19, 2021 Category: Consumer Health News Source Type: news
What Things Can Make Narcolepsy Worse?
Narcolepsy attacks can come and go. How well you sleep at night might affect how often you have bouts of extreme sleepiness during the day. (Source: WebMD Health)
Source: WebMD Health - July 16, 2021 Category: Consumer Health News Source Type: news
How to Navigate Relationships With Narcolepsy
Narcolepsy can affect many different parts of your life, including the relationships you build. Learn about the challenges of maintaining relationships when you have narcolepsy and ways to navigate those relationships. (Source: WebMD Health)
Source: WebMD Health - July 12, 2021 Category: Consumer Health News Source Type: news
Narcolepsy and Your Diet
Learn about the link between narcolepsy and obesity, best foods for narcolepsy, how and when to eat, and if a low-carb or keto diet helps with symptoms. (Source: WebMD Health)
Source: WebMD Health - July 9, 2021 Category: Consumer Health News Source Type: news
Levels of GHB in hair after regular application - Nebel A, Mayer G, Hess C, Heidbreder A, Martz W, Veit F.
Gamma hydroxybutyrate (GHB) is a central nervous system depressant that is an approved drug for the treatment of narcolepsy with cataplexy and other syndromes. Due to its dose dependent stimulating, relaxing or sedative effects, illicit abuses include recr... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
European guideline and expert statements on the management of narcolepsy in adults and children - Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, Dolenc-Groselj L, Jennum P, Khatami R, Manconi M, Mayer G, Partinen M, Pollm ächer T, Reading P, Santamaria J, Sonka K, Dauvilliers Y, Lammers GJ.
BACKGROUND AND AIM: Narcolepsy is an uncommon hypothalamic disorder of presumed autoimmune origin that usually requires lifelong treatment. This paper aims to provide evidence-based guidelines for the management of narcolepsy in both adults and children. ... (Source: SafetyLit)
Source: SafetyLit - July 2, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
European guideline and expert statements on the management of narcolepsy in adults and children - Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, Dolenc-Groselj L, Jennum P, Khatami R, Manconi M, Mayer G, Partinen M, Pollm ächer T, Reading P, Santamaria J, Sonka K, Dauvilliers Y, Lammers GJ.
BACKGROUND AND PURPOSE: Narcolepsy is an uncommon hypothalamic disorder of presumed autoimmune origin that usually requires lifelong treatment. This paper aims to provide evidence-based guidelines for the management of narcolepsy in both adults and childre... (Source: SafetyLit)
Source: SafetyLit - June 28, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution
U.S. Food and Drug Administration published its summary of clinical superiority findings for Xywav for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older with narcolepsy by means of greater safety compared to Xy... Biopharmaceuticals, FDA Jazz Pharmaceuticals, Xywav, Cataplexy, Narcolepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2021 Category: Pharmaceuticals Source Type: news
Once-Nightly Sodium Oxybate Agent Effective in Narcolepsy Once-Nightly Sodium Oxybate Agent Effective in Narcolepsy
An investigational, once-nightly formulation of sodium oxybate is safe and effective for treating both subjective and objective symptoms of narcolepsy, results from the phase 3 REST-ON trial show.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 30, 2021 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news
NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer
STANS, Switzerland, April 5, 2021 -- (Healthcare Sales & Marketing Network) -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and developmen... Biopharmaceuticals, Neurology, Personnel NLS Pharmaceutics, Quilience, narcolepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2021 Category: Pharmaceuticals Source Type: news
Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy
DUBLIN, Ireland, March 01, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s New Drug... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 1, 2021 Category: Drugs & Pharmacology Source Type: news
